M&A | Ophthalmology Innovation Source

Allergan’s Oculeve Acquisition Bolsters Dry Eye, Medtech

The dry eye space has taken a few hits lately with disappointing clinical news on the biopharmaceutical front. But investors and entrepreneurs developing new treatments have to be bolstered by Allergan’s agreeing to purchase early-stage company Oculeve. According to a press release on the deal, Allergan would pay $125 million up front for Oculeve, which…

Oculeve Open Ups, Just A Little, On OD-01

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 047″] In this week’s OIS Podcast, we talk with Oculeve CEO Michael Ackermann about the start-up company that caught the eye of Dry Eye Leader Allergan. The dry eye space has taken a few hits lately with disappointing clinical news on the biopharmaceutical front. But the news that Allergan would pay…

2015 Review of the Ophthalmology Innovation Cycle

Moderator: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. View Full Profile Panelists: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus at…

Alternative Financing Approaches

Moderator: Tom Salemi Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products. View Full Profile Panelists: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President…

Co-Chair Link Gives Overview Of Upcoming OIS

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 033″] With just two weeks away from OIS@ASCRS, Conference Co-Chair Bill Link, managing director of Versant Ventures, reviews the highlights of the upcoming meeting including a tight focus on glaucoma and plenary talk by J. Michael Pearson of Valeant. Podcast Guests William J. Link, PhD Bill was Founder, Chairman and CEO…

Alcon’s Plan For WaveTec’s ORA System

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 028″] Alcon’s Warner, Tom Frinzi Discuss the WaveTec Vision Acquisition Details. Podcast Guest Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. Prior to joining Abbott, Mr. Frinzi held a…

Cunningham: 2015 Could Be A Big Year For Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 020″] OIS Co-Chair Emmett Cunningham delivers a high altitude review of the much sought after “Year in Review” report he delivers at each event. In this review, Cunningham touched upon his hopes for the sector & OIS. Podcast Guest Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham joined Clarus Ventures…

Jeff George’s Vision for Innovation at Alcon

Jeff George, Global Head of Alcon, took a few minutes between panels and meetings to share his vision for innovation at Alcon and how the company will pursue many opportunities in ophthalmology. Speaking With: Jeff George Jeff was appointed to lead Alcon in May 2014. As the global leader in eye care, Alcon provides innovative…

How to Do M&A Well

Highlights of a discussion between the ophthalmology sector’s top execs about how to do M&A right. Moderator: Jim Mazzo Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved. View Full Profile Panelists: Jeff George Jeff was…

Private Funding Trends In Healthcare

Jon Norris, senior vice president of Silicon Valley Bank, delivers a comprehensive report on the state of private opthalmology financing. Presenter: Jonathan Norris Jon Norris is a Managing Director with SVB Healthcare team, responsible for new business development. View Full Profile

CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

Building a successful biotech or biopharma company typically turns on a sentinel event — the pivot, as William J. Link, PhD, Managing Director of Versant Ventures calls it. That can involve a complete shift in a company’s focus. Link hosted a panel at the Ophthalmology Innovation Summit in Chicago, where CEOs and founders explained how…

AAO Sees Good and Bad in Consolidation

Speaking at the recent OIS@AAO meeting, American Academy of Ophthalmology EVP and CEO David W. Parke II, MD, highlighted health care system integration forces that are aggregating physicians into larger groups, encouraging hospital mergers, and accelerating physician employment. Much of the consolidation is happening as part of the push towards accountable care organizations (ACOs). About…